

[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
[ Mon, May 15th 2023
] - WOPRAI
Judah Frommer Maintained (SRPT) at Hold with Increased Target to $151 on, May 15th, 2023
Judah Frommer of Credit Suisse, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Increased Target from $138 to $151 on, May 15th, 2023.
Judah has made no other calls on SRPT in the last 4 months.
There are 12 other peers that have a rating on SRPT. Out of the 12 peers that are also analyzing SRPT, 0 agree with Judah's Rating of Hold.
These are the ratings of the 12 analyists that currently disagree with Judah
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $197 on, Wednesday, May 3rd, 2023
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $158 on, Wednesday, May 3rd, 2023
- David Hoang of "SMBC Nikko" Initiated at Buy and Held Target at $185 on, Wednesday, April 26th, 2023
- Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Friday, April 14th, 2023
- Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $179 on, Tuesday, April 4th, 2023
- Ritu Baral of "TD Cowen" Maintained at Buy with Increased Target to $175 on, Wednesday, March 22nd, 2023
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $150 on, Thursday, March 9th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $206 on, Friday, March 3rd, 2023
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Wednesday, March 1st, 2023
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, March 1st, 2023
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $187 on, Wednesday, March 1st, 2023
- Joseph Schwartz of "SVB Leerink" Reiterated at Buy and Held Target at $160 on, Friday, January 20th, 2023
Contributing Sources